6.
Lehman N, Mazery A, Visier A, Baumann C, Lachesnais D, Capri Y
. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet. 2017; 92(3):298-305.
DOI: 10.1111/cge.13010.
View
7.
Lederer D, Grisart B, Digilio M, Benoit V, Crespin M, Ghariani S
. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet. 2011; 90(1):119-24.
PMC: 3257878.
DOI: 10.1016/j.ajhg.2011.11.021.
View
8.
Parisi L, Di Filippo T, Roccella M
. Autism spectrum disorder in Kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases. Minerva Pediatr. 2015; 67(4):369-75.
View
9.
Wessels M, Brooks A, Hoogeboom J, Niermeijer M, Willems P
. Kabuki syndrome: a review study of three hundred patients. Clin Dysmorphol. 2002; 11(2):95-102.
DOI: 10.1097/00019605-200204000-00004.
View
10.
Verhagen J, Oostdijk W, van Scheltinga C, Schalij-Delfos N, van Bever Y
. An unusual presentation of Kabuki syndrome: clinical overlap with CHARGE syndrome. Eur J Med Genet. 2014; 57(9):510-2.
DOI: 10.1016/j.ejmg.2014.05.005.
View
11.
Banka S, Veeramachaneni R, Reardon W, Howard E, Bunstone S, Ragge N
. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet. 2011; 20(4):381-8.
PMC: 3306863.
DOI: 10.1038/ejhg.2011.220.
View
12.
Oswald F, Rodriguez P, Giaimo B, Antonello Z, Mira L, Mittler G
. A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes. Nucleic Acids Res. 2016; 44(10):4703-20.
PMC: 4889922.
DOI: 10.1093/nar/gkw105.
View
13.
Baldridge D, Spillmann R, Wegner D, Wambach J, White F, Sisco K
. Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome. Am J Med Genet A. 2020; 182(5):1053-1065.
PMC: 7295006.
DOI: 10.1002/ajmg.a.61518.
View
14.
Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T
. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981; 99(4):565-9.
DOI: 10.1016/s0022-3476(81)80255-7.
View
15.
Morin R, Mendez-Lago M, Mungall A, Goya R, Mungall K, Corbett R
. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011; 476(7360):298-303.
PMC: 3210554.
DOI: 10.1038/nature10351.
View
16.
Van Laarhoven P, Neitzel L, Quintana A, Geiger E, Zackai E, Clouthier D
. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015; 24(15):4443-53.
PMC: 4492403.
DOI: 10.1093/hmg/ddv180.
View
17.
Yap K, Knight Johnson A, Fischer D, Kandikatla P, Deml J, Nelakuditi V
. Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals". Genet Med. 2018; 21(1):262-265.
DOI: 10.1038/s41436-018-0126-1.
View
18.
Bjornsson H, Benjamin J, Zhang L, Weissman J, Gerber E, Chen Y
. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med. 2014; 6(256):256ra135.
PMC: 4406328.
DOI: 10.1126/scitranslmed.3009278.
View
19.
Boniel S, Szymanska K, Smigiel R, Szczaluba K
. Kabuki Syndrome-Clinical Review with Molecular Aspects. Genes (Basel). 2021; 12(4).
PMC: 8064399.
DOI: 10.3390/genes12040468.
View
20.
Kawame H, Hannibal M, Hudgins L, Pagon R
. Phenotypic spectrum and management issues in Kabuki syndrome. J Pediatr. 1999; 134(4):480-5.
DOI: 10.1016/s0022-3476(99)70207-6.
View